Cervical cancer · 2 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Cisplatin and Paclitaxel (TP) Variant #02 | — | R 1 315 | 21d | — | 12.9 mo | 7 | R 9 204 PFS proxy | 5 |
Carboplatin and Paclitaxel (CP) Variant #02 | — | R 1 025 | 21d | — | 17.2 mo | 18 | R 18 445 PFS proxy | 4 |
2 of 2 regimens shown